ClinicalTrials.govpublic full text
Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors
solid tumor cancer, solid tumor cancer treatment with immunotherapy, cytotoxic antibody, pd-l1, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 843741
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.